Vincenzo Bagnardi
Overview
Explore the profile of Vincenzo Bagnardi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
257
Citations
5330
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Conforti F, Pala L, Di Mitri D, Catania C, Cocorocchio E, Laszlo D, et al.
Cancer Cell
. 2025 Mar;
43(3):343-360.
PMID: 40068594
Sex-based differences have been observed in the incidence and prognosis of various cancers, as well as in the response to immune check point inhibitors (ICIs). These disparities are partially attributed...
2.
Pala L, Merlo F, Sala I, Pagan E, Oriecuia C, Specchia C, et al.
J Natl Cancer Inst
. 2025 Mar;
PMID: 40036179
Background: The surrogacy of overall response-rate (ORR) or progression-free survival (PFS) for overall survival (OS) at the trial-level in randomized clinical trials (RCTs) testing antibody-drugs conjugates (ADC) has never been...
3.
Magistri P, Zamboni S, Catellani B, Guidetti C, Esposito G, Caracciolo D, et al.
Artif Organs
. 2025 Feb;
PMID: 39969150
Introduction: Liver transplantation (LT) is the sole curative option for liver failure and other primary liver conditions. However, the limited number of suitable donors compared with the growing number of...
4.
Conforti F, Nekljudova V, Sala I, Ascari R, Solbach C, Untch M, et al.
J Clin Oncol
. 2025 Jan;
:JCO2401360.
PMID: 39883887
Purpose: To assess trial-level surrogacy value for overall survival (OS) of the pathologic complete response (pCR) and invasive disease-free survival (iDFS) in randomized clinical trials (RCTs) for early breast cancer...
5.
Canonica G, Blasi F, Paggiaro P, Heffler E, Braido F, Brussino L, et al.
World Allergy Organ J
. 2025 Jan;
18(1):101016.
PMID: 39829953
Background: This study aimed to evaluate the impact of severe asthma (SA) treatments after 12 months in achieving clinical remission (CR) within the context of the Severe Asthma Network in...
6.
Nicosia L, Mariano L, Mallardi C, Sorce A, Frassoni S, Bagnardi V, et al.
Cancers (Basel)
. 2025 Jan;
17(1.
PMID: 39796642
Contrast-enhanced mammography (CEM) has recently gained recognition as an effective alternative to breast magnetic resonance imaging (MRI) for assessing breast lesions, offering both morphological and functional imaging capabilities. However, the...
7.
Vicini E, Galimberti V, Leonardi M, Kahler-Ribeiro-Fontana S, Polizzi A, Petitto S, et al.
Breast Cancer Res Treat
. 2025 Jan;
PMID: 39776333
Purpose: The use of neoadjuvant systemic therapy for primary breast cancer can achieve tumor shrinkage, enabling less invasive surgical treatments, such as breast-conserving surgery instead of mastectomy, and sentinel node...
8.
Possenti I, Romelli M, Carreras G, Biffi A, Bagnardi V, Specchia C, et al.
Eur Respir Rev
. 2024 Nov;
33(174).
PMID: 39537242
Background: Lung cancer ranks as the leading cause of cancer-related deaths worldwide. There is evidence that second-hand smoke (SHS) exposure is a risk factor for the development of lung cancer...
9.
Lisa A, Mela A, Miranda S, Alessandri Bonetti M, Bottoni M, Intra M, et al.
J Clin Med
. 2024 Oct;
13(20).
PMID: 39458226
: The reconstruction of large breasts carries a heightened risk profile. While skin-reducing mastectomy (SRM) techniques facilitate the correction of breast ptosis, they are frequently associated with a high incidence...
10.
Caprara G, Pagan E, Titta L, Tieri M, Magionesi G, Gallosti S, et al.
Front Oncol
. 2024 Oct;
14:1436610.
PMID: 39386191
Introduction: Several studies have demonstrated that, following a breast cancer (BC) diagnosis, patients are eager to obtain information on cancer and nutrition, in order to ameliorate both their quality of...